Sponsored
Sponsored
Media Summary: What were the key takeaways from this year's In this next LIVE episode we will be shining the spotlight on really exciting news straight from the Join the faculty as they discuss updates changes in steatotic liver disease nomenclature.  ...

Easl Studio S9e10 Decoding Aasld - Detailed Analysis & Overview

What were the key takeaways from this year's In this next LIVE episode we will be shining the spotlight on really exciting news straight from the Join the faculty as they discuss updates changes in steatotic liver disease nomenclature.  ... Dr. Anthony Martinez, Medical Director of Hepatology at the University at Buffalo and Erie County Medical Center, discusses the ... After years of limited progress, recent trials hint at a changing landscape for primary sclerosing cholangitis (PSC). In this episode ... Alcohol related liver disease remains the most important cause of liver disease morbidity and mortality in Europe and North ...

GUEST: Gerd Kullak-Ublick. Novel biomarkers for the assessment of drug-induced liver injury. Dive into the intricate world of hepatitis B virus (HBV) management with our comprehensive medical education video. Designed ... May 21 2026, This extended LabCoP ECHO session focuses on collaboration with the Global Laboratory Initiative (GLI) and FIND, ... Two major developments—the recommendation for birth cohort screening and the recent approval of all-oral treatment ... Prof. Dr. Matter Matthias. An integrated single-cell atlas of checkpoint inhibitor-induced liver injury links shared liver-tumour CD8+ ...

Photo Gallery

EASL Studio S9E10 - Decoding AASLD The Liver Meeting: Trends Shaping Hepatology
EASL Studio - Wednesday 17 November at 18:00 CET (Live from the AASLD Liver Meeting)
EASL Studio interview with AASLD Key Opinion Leader Prof. Mary Rinella on 27 August 2020
EASL Studio Midday Talks: Steatotic liver disease global consensus to change nomenclature
Insights From 2025 EASL & AASLD Chronic Hepatitis B Guidelines
EASL Studio S9E6 - Are we finally entering an era of effective treatment for PSC?
Debrief from EASL-AASLD Conference: Alcohol related Liver Disease
EASL Studio at EASL Congress 2024 - Deciphering the drivers of cirrhosis decompensation
20.05.2026. International Seminar Series on Liver Toxicity and Steatotic Liver Disease
Hepatitis B virus 2: Dive into HBV Management: Key Differences Between EASL and AASLD
May 21 2026 LabCoP Ext ECHO Session: Stepwise Implementation of Diagnostic Network Optimization
AASLD/EASL Special Conference Session 3: Therapeutic Options
View Detailed Profile
EASL Studio S9E10 - Decoding AASLD The Liver Meeting: Trends Shaping Hepatology

EASL Studio S9E10 - Decoding AASLD The Liver Meeting: Trends Shaping Hepatology

What were the key takeaways from this year's

EASL Studio - Wednesday 17 November at 18:00 CET (Live from the AASLD Liver Meeting)

EASL Studio - Wednesday 17 November at 18:00 CET (Live from the AASLD Liver Meeting)

In this next LIVE episode we will be shining the spotlight on really exciting news straight from the

Sponsored
EASL Studio interview with AASLD Key Opinion Leader Prof. Mary Rinella on 27 August 2020

EASL Studio interview with AASLD Key Opinion Leader Prof. Mary Rinella on 27 August 2020

EASL Studio

EASL Studio Midday Talks: Steatotic liver disease global consensus to change nomenclature

EASL Studio Midday Talks: Steatotic liver disease global consensus to change nomenclature

Join the faculty as they discuss updates changes in steatotic liver disease nomenclature. @AASLDVideo @jhepatology ...

Insights From 2025 EASL & AASLD Chronic Hepatitis B Guidelines

Insights From 2025 EASL & AASLD Chronic Hepatitis B Guidelines

Dr. Anthony Martinez, Medical Director of Hepatology at the University at Buffalo and Erie County Medical Center, discusses the ...

Sponsored
EASL Studio S9E6 - Are we finally entering an era of effective treatment for PSC?

EASL Studio S9E6 - Are we finally entering an era of effective treatment for PSC?

After years of limited progress, recent trials hint at a changing landscape for primary sclerosing cholangitis (PSC). In this episode ...

Debrief from EASL-AASLD Conference: Alcohol related Liver Disease

Debrief from EASL-AASLD Conference: Alcohol related Liver Disease

Alcohol related liver disease remains the most important cause of liver disease morbidity and mortality in Europe and North ...

EASL Studio at EASL Congress 2024 - Deciphering the drivers of cirrhosis decompensation

EASL Studio at EASL Congress 2024 - Deciphering the drivers of cirrhosis decompensation

Deciphering

20.05.2026. International Seminar Series on Liver Toxicity and Steatotic Liver Disease

20.05.2026. International Seminar Series on Liver Toxicity and Steatotic Liver Disease

GUEST: Gerd Kullak-Ublick. Novel biomarkers for the assessment of drug-induced liver injury.

Hepatitis B virus 2: Dive into HBV Management: Key Differences Between EASL and AASLD

Hepatitis B virus 2: Dive into HBV Management: Key Differences Between EASL and AASLD

Dive into the intricate world of hepatitis B virus (HBV) management with our comprehensive medical education video. Designed ...

May 21 2026 LabCoP Ext ECHO Session: Stepwise Implementation of Diagnostic Network Optimization

May 21 2026 LabCoP Ext ECHO Session: Stepwise Implementation of Diagnostic Network Optimization

May 21 2026, This extended LabCoP ECHO session focuses on collaboration with the Global Laboratory Initiative (GLI) and FIND, ...

AASLD/EASL Special Conference Session 3: Therapeutic Options

AASLD/EASL Special Conference Session 3: Therapeutic Options

Two major developments—the recommendation for birth cohort screening and the recent approval of all-oral treatment ...

AASLD/EASL HCV Special Conference Session 1: Birth Cohort Screening for HCV

AASLD/EASL HCV Special Conference Session 1: Birth Cohort Screening for HCV

Two major developments—the recommendation for birth cohort screening and the recent approval of all-oral treatment ...

15.04.2026. International Seminar Series on Liver Toxicity and Steatotic Liver Disease

15.04.2026. International Seminar Series on Liver Toxicity and Steatotic Liver Disease

Prof. Dr. Matter Matthias. An integrated single-cell atlas of checkpoint inhibitor-induced liver injury links shared liver-tumour CD8+ ...

EASL Studio S3E11 - Regenerative Hepatology: from stem cells to tissue engineering

EASL Studio S3E11 - Regenerative Hepatology: from stem cells to tissue engineering

Watch the full episode on demand: ...

Related Video Content

EASL | The Home of Hepatology information

3 days ago · EASL’s mission is to be the Home of Hepatology so all who are involved with treating liver disease can...

Easel ® | CNC Software | Official Site information

Discover Easel, the browser-based CAD/CAM software for 3D carving, and Easel Cabinetmaker for effortless cabinet...

EASL 2026 | EASL 2026 Registration | EASL 2026 Annual Congress information

Founded in 1966, the European Association for the Study of the Liver (EASL) has grown from a small circle of...

EASL Conferences information

2025: 45th EASL conference, held in London (10-12 September 2025). On the following subpages we present the minutes...

EASL Clinical Practice Guidelines on the management of hepatitis B ... information

The European Association for the Study of the Liver (EASL) clinical practice guidelines (CPGs) on HBV have been...

Sponsored